Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

AAclaris Therapeutics, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
A

Aclaris Therapeutics, Inc.

$5.72Close · Sep 22, 2026
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • Insider Transactions
Loading financials
Income statement waterfall. Revenue $1.63M. Net result −$21.51M. A thin axis line marks the loss-zone boundary.

Income statement waterfall. Green diagonal stripes add to the running result, red diagonal stripes subtract from it, and a thin axis line marks the loss-zone boundary.

  • Revenue: $1.63M. Running result $1.63M. Laboratory Research Revenue: $356K. License And Service: $1.27M.
  • Cost of revenue: −$218K. Running result $1.41M.
  • Gross profit: $1.41M. Running result $1.41M.
  • Research and development: −$18.07M. Running result −$16.66M.
  • General and administrative: −$6.05M. Running result −$22.7M.
  • Licensing: −$1.24M. Running result −$23.94M.
  • Revaluation of contingent consideration: −$300K. Running result −$24.24M.
  • Operating income: −$24.24M. Running result −$24.24M.
  • Other income: $2.73M. Running result −$21.51M.
  • Pre-tax loss: −$21.51M. Running result −$21.51M.
  • Income tax benefit: $0. Running result −$21.51M.
  • Net loss: −$21.51M. Running result −$21.51M.